High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.

Saved in:

Bibliographic Details
Title:	High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT.
Authors:	Hengeveld, M¹, Suciu, S², Chelgoum, Y³, Marie, J-P⁴, Muus, P¹, Lefrère, F⁵, Mandelli, F⁶, Pane, F⁷, Amadori, S⁸, Fioritoni, G⁹, Labar, B¹⁰, Baron, F¹¹, Cermak, J¹², Bourhis, J-H¹³, Storti, G¹⁴, Fazi, P¹⁵, Hagemeijer, A¹⁶, Vignetti, M¹⁵, Willemze, R¹⁷, de Witte, T¹
Source:	Bone Marrow Transplantation. Mar2015, Vol. 50 Issue 3, p341-347. 7p.
Database:	Academic Search Ultimate

Description
ISSN:	02683369
DOI:	10.1038/bmt.2014.262